Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions.
Plasma concentrations of oil particles after intravenous injection of oil-in-water (O/W) lipid emulsions were monitored based on the plasma concentration of phospholipids (PL) and triglycerides (TG), and the light scattering intensity (LSI) of plasma. Previously, we found that their time profiles after injection of the standard O/W lipid emulsion composed of soybean oil (SO) and egg yolk phosphatides (EYP) were similar and suggested that the oil particles with diameter of about 200 nm were entrapped by reticuloendothelial system (RES). Herein, in order to develop a delivery system to avoid the RES uptake by using the lipid emulsions, biological fate of lipid emulsions with oil particles of various sizes or those emulsified by surfactants with polyoxyethylene segments were subjected to the investigations. Lipid emulsions with oil particles of various sizes (about 150-550 nm) were prepared by altering EYP content. The oil particles were stable in plasma in vitro, but oil particle size decreased time-dependently after intravenous injection. Plasma clearance of oil particles depended on their initial size and was decreased by pretreatment with dextran sulfate 500 (DS500), a known RES suppressor. These results suggested that oil particles are still entrapped by RES, even for small-sized oil particles (about 150 nm). Lipid emulsion with small-sized oil particles was also prepared using medium chain triglycerides. The oil particles were stable in vitro, but the time profiles of plasma concentrations of PL and TG, and LSI of plasma were different, and oil particle size decreased time-dependently after intravenous injection. Plasma clearance of the oil particles also depended on their initial size and was decreased by DS500, suggesting that in vivo instability could be due to RES-mediated processes. Artificial surfactants with polyoxyethylene segments, HCO-60 (HCO60) and polysorbate 80 (PS80), were used for RES avoidance. HCO60 resulted in drastic reduction of the plasma clearance of the oil particles for both lipid emulsions composed of soybean oil and medium chain triglycerides. The time-dependent decrease of oil particle size after intravenous injection was marginal. In contrast, PS80 could not prolong the circulation time of the oil particles, and their size decreased time-dependently after intravenous injection.
Sakaeda
T
T
Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka, Japan.
Hirano
K
K
D000818:Animals; D002368:Castor Oil / Q000031:analogs & derivatives; D016264:Dextran Sulfate; D004337:Drug Carriers; D004655:Emulsions; D005079:Excipients; D006207:Half-Life; D007202:Indicators and Reagents; D007275:Injections, Intravenous; D008297:Male; D010316:Particle Size; D010743:Phospholipids; D011136:Polysorbates; D051381:Rats; D017208:Rats, Wistar; D013024:Soybean Oil / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics*; D014280:Triglycerides / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics*; D014867:Water / Q000737:chemistry
D004337:Drug Carriers; D004655:Emulsions; D005079:Excipients; D007202:Indicators and Reagents; D010743:Phospholipids; D011136:Polysorbates; D014280:Triglycerides; D014867:Water; C023040:polyethoxylated castor oil; D013024:Soybean Oil; D002368:Castor Oil; D016264:Dextran Sulfate